<!DOCTYPE HTML>
<html>
<head>
<meta http-equiv="Content-Type" content="text/html; charset=utf-8" />
<meta http-equiv="Content-Language" content="en-US" />
 <meta name="generator" content="Adobe RoboHelp 2017" />
<title>Recording Trial Details</title>
<link rel="StyleSheet" href="default.css" type="text/css" />
<script type="text/javascript" language="JavaScript">
//<![CDATA[
function reDo() {
  if (innerWidth != origWidth || innerHeight != origHeight)
     location.reload();
}
if ((parseInt(navigator.appVersion) == 4) && (navigator.appName == "Netscape")) {
	origWidth = innerWidth;
	origHeight = innerHeight;
	onresize = reDo;
}
onerror = null; 
//]]>
</script>
<style type="text/css">
<!--
div.WebHelpPopupMenu { position:absolute;
left:0px;
top:0px;
z-index:4;
visibility:hidden; }
p.WebHelpNavBar { text-align:right; }
-->
</style>

<script type="text/javascript" src="template/scripts/rh.min.js"></script>
<script type="text/javascript" src="template/scripts/common.min.js"></script>
<script type="text/javascript" src="template/scripts/topic.min.js"></script>
<script type="text/javascript" src="template/scripts/constants.js"></script>
<script type="text/javascript" src="template/scripts/utils.js"></script>
<script type="text/javascript" src="template/scripts/mhutils.js"></script>
<script type="text/javascript" src="template/scripts/mhlang.js"></script>
<script type="text/javascript" src="template/scripts/mhver.js"></script>
<script type="text/javascript" src="template/scripts/settings.js"></script>
<script type="text/javascript" src="template/scripts/XmlJsReader.js"></script>
<script type="text/javascript" src="template/scripts/loadparentdata.js"></script>
<script type="text/javascript" src="template/scripts/loadscreen.js"></script>
<script type="text/javascript" src="template/scripts/loadprojdata.js"></script>
<script type="text/javascript" src="template/scripts/mhtopic.js"></script>
 <link rel="stylesheet" type="text/css" href="template/styles/widgets.min.css">
 <link rel="stylesheet" type="text/css" href="template/styles/topic.min.css">
<script type="text/javascript" >
gRootRelPath = ".";
gCommonRootRelPath = ".";
gTopicId = "1.1.1.0_2";
</script>
 <meta name="brsprev" value="Recording_Trial_Identification_Information.htm">
 <meta name="brsnext" value="Trial_Registration_Reference.htm">
 <meta name="topic-breadcrumbs" content="Trial Registration Tasks > Registering New Trials > Registering New Complete Trials" />
</head>

<body>
<script type="text/javascript" src="./ehlpdhtm.js"></script>


<h1>Recording Trial Details</h1>
<p><strong>How to Complete the Trial Details Section</strong></p>
<ol>
	<li><p>In the various fields, specify the appropriate information. 
	 The following table describes the fields. An asterisk (*) indicates 
	 a required field.</p></li>
	<table class="wrapped confluenceTable tablesorter tablesorter-default" 
			 role="grid" style="vertical-align: top;">
		<tr role="row">
			<td class="confluenceTd"><p><strong>Title*</strong></p></td>
			<td class="confluenceTd"><p>Enter the <a href="javascript:TextPopup(this)" id="HotSpot18212" class="glossterm">title</a><script type="text/javascript">//<![CDATA[
TextPopupInit('HotSpot18212', 'POPUP18212');
//]]></script><span class="glosstext" id="POPUP18212" style="display: none;"> The official name of the protocol provided by the study principal investigator or sponsor.</span> 
			 of the trial. (Limit 4000 characters.) For example: &quot;Study 
			 of Recombinant Vaccinia Virus That Expresses Prostate Specific 
			 Antigen in Metastatic Adenocarcinoma of the Prostate&quot;</p></td>
		</tr>
		<tr role="row">
			<td class="confluenceTd"><p><strong>Phase*</strong></p></td>
			<td class="confluenceTd"><div class="content-wrapper">
				<p>Select the <a href="javascript:TextPopup(this)" id="HotSpot13534" class="glossterm">phase</a><script type="text/javascript">//<![CDATA[
TextPopupInit('HotSpot13534', 'POPUP13534');
//]]></script><span class="glosstext" id="POPUP13534" style="display: none;"> The phase or stage of the clinical trial as defined by the US FDA.</span> 
				 of the trial, from the drop-down list. For valid values, 
				 refer to <a href="Trial_Phase_Value_Definitions.htm">Trial 
				 Phase Value Definitions</a>. Select<strong> N/A</strong> 
				 for observational and ancillary-correlative trials.</p>
			</div></td>
		</tr>
		<tr>
			<td><p><strong>Is this a Pilot?</strong></p></td>
			<td>Select <strong>Yes</strong> or <strong>No</strong> from 
			 the drop-down list to indicate whether the trial you are registering 
			 is a pilot trial.</td>
		</tr>
		<tr>
			<td><p><strong>Trial Type*</strong></p></td>
			<td>Select the trial type indicated in the protocol.&#160;</td>
		</tr>
	</table>
	<li>If you selected interventional as the trial type, select or enter 
	 the appropriate information in the following fields. The following 
	 table describes the fields. An asterisk (*) indicates a required field.</li>
	<div class="table-wrap">
		<table class="wrapped confluenceTable tablesorter tablesorter-default stickyTableHeaders" 
				 role="grid" style="padding: 0px;">
			<tr role="row">
				<td class="confluenceTd"><p><strong>Primary Purpose*</strong></p></td>
				<td class="confluenceTd"><div class="content-wrapper">
					<ol>
						<li><p>Select the primary reason for conducting 
						 the trial. The following list provides valid values.</p>
						<ul class="conf-macro output-block" data-hasbody="false" 
								 data-macro-name="include">
							<li><strong>Treatment</strong>. Protocol is 
							 designed to evaluate one or more interventions 
							 for treating a disease, syndrome, or condition.</li>
							<li><strong>Prevention</strong>. Protocol is 
							 designed to assess one or more interventions 
							 aimed at preventing the development of a specific 
							 disease or health condition.</li>
							<li><strong>Supportive Care</strong>. Protocol 
							 is designed to evaluate one or more interventions 
							 where the primary intent is to maximize comfort, 
							 minimize side effects or mitigate against 
							 a decline in the subject's health or function. 
							 In general, supportive care interventions 
							 are not intended to cure a disease.</li>
							<li><strong>Screening</strong>. Protocol is 
							 designed to assess or examine methods of identifying 
							 a condition (or risk factors for a condition) 
							 in people who are not yet known to have the 
							 condition (or risk factor).</li>
							<li><strong>Diagnostic</strong>. Protocol is 
							 designed to evaluate one or more interventions 
							 aimed at identifying a disease or health condition.</li>
							<li><strong>Health Services Research</strong>. 
							 Protocol is designed to evaluate the delivery, 
							 processes, management, organization, or financing 
							 of health care.</li>
							<li><strong>Basic Science</strong>. Protocol 
							 is designed to examine the basic mechanism 
							 of action (e.g., physiology, biomechanics) 
							 of an intervention.</li>
							<li><strong>Device Feasibility</strong>. Protocol 
							 is designed to evaluate an intervention of 
							 a device product, to determine the feasibility 
							 of the product or to test a prototype device 
							 and not health outcomes. Such studies are 
							 conducted to confirm the design and operating 
							 specifications of a device before beginning 
							 a full clinical trial.</li>
							<li><strong>Other</strong>. Any purpose not 
							 described above.</li>
						</ul></li>
						<li>Optionally, if the primary purpose is <strong>Other</strong>, 
						 type a detailed description of the trial’s purpose 
						 in the text field provided.</li>
					</ol>
					<div class="confluence-information-macro confluence-information-macro-information conf-macro output-block" 
						 data-hasbody="true" data-macro-name="info">
						<span class="aui-icon aui-icon-small aui-iconfont-info confluence-information-macro-icon">&#160;</span> 
						 
						<div class="confluence-information-macro-body">
							<p>The text field is displayed only after you 
							 have selected <strong>Other</strong>. The 
							 limit is 200 characters; the system counts 
							 down the character numbers as you type.</p>
						</div>
					</div>
				</div></td>
			</tr>
			<tr role="row">
				<td class="confluenceTd"><strong>Secondary Purpose</strong></td>
				<td class="confluenceTd"><div class="content-wrapper">
					<ol>
						<li><p>Select one of the following reasons for 
						 conducting the trial.</p>
						<ul class="conf-macro output-block" data-hasbody="false" 
								 data-macro-name="include">
							<li><div class="conf-macro output-block" data-hasbody="false" 
									 data-macro-name="include">
								<strong>Ancillary-Correlative</strong>. 
								 A trial that is secondary to another trial, 
								 or a type of trial that tests for a relationship 
								 between a condition and a potential causal 
								 factor of the condition. 
								<ul>
									<li><span style="color: #000000;"><strong>Ancillary.</strong> 
									 Studies that are stimulated by, but 
									 are not a required part of, a main 
									 clinical trial/study, and that utilize 
									 patient or other resources of the 
									 main trial/study to generate information 
									 relevant to it. Ancillary studies 
									 must be linked to an active clinical 
									 research study and should include 
									 only patients accrued to that clinical 
									 research study. <span style="color: #000000;">Report 
									 only those studies that can be linked 
									 to individual patient or participant 
									 data</span>.</span></li>
									<li><span style="color: #000000;"><strong>Correlative.</strong> 
									 Laboratory-based studies using specimens 
									 to assess cancer risk, clinical outcomes, 
									 response to therapies, etc. Report 
									 only those studies that can be linked 
									 to individual patient or participant 
									 data.<br />
									</span></li>
								</ul>
							</div></li>
							<li><strong>Other</strong>.&#160;&#160;Any 
							 purpose other than Ancillary-Correlative.</li>
						</ul></li>
						<li>If the secondary purpose is <strong>Other</strong>, 
						 enter a detailed description of the trial’s purpose 
						 in the text field provided.</li>
					</ol>
				</div></td>
			</tr>
			<tr role="row">
				<td class="confluenceTd"><div class="content-wrapper">
					<strong>Accrual Disease Terminology*<span class="confluence-anchor-link conf-macro output-inline" 
					 id="RecordingTrialDetails-7316" data-hasbody="false" 
					 data-macro-name="anchor"> </span><br />
					</strong> 
				</div></td>
				<td class="confluenceTd"><p>Click to select the disease 
				 terminology used to report subject accruals for this trial.</p></td>
			</tr>
		</table>
	</div>
	<li>If you selected non-interventional as the trial type, select or 
	 enter the appropriate information in the following fields. The following 
	 table describes the fields. An asterisk (*) indicates a required field.</li>
	<table class="wrapped confluenceTable tablesorter tablesorter-default stickyTableHeaders" 
			 role="grid" style="padding: 0px;">
		<tr role="row">
			<td class="confluenceTd"><strong>Non-Interventional Trial Type*</strong></td>
			<td class="confluenceTd"><div class="content-wrapper">
				<p>Select one of the following trial types:</p>
				<ul>
					<li><div class="conf-macro output-block" data-hasbody="false" 
							 data-macro-name="include">
						<strong>Observational</strong>. Studies among cancer 
						 patients and healthy populations that involve 
						 no interventions or alteration of the participants.<span 
						 style="color: #000000;"> Biomedical and/or health 
						 outcome(s) are assessed in pre-defined groups 
						 of participants. The participants in the study 
						 may receive diagnostic, therapeutic, or other 
						 interventions but the investigator of the observational 
						 study is not responsible for assigning specific 
						 interventions to the participants of the study.</span> 
						 
					</div></li>
					<li><div class="conf-macro output-block" data-hasbody="false" 
							 data-macro-name="include">
						<strong>Ancillary-Correlative</strong>. A trial 
						 that is secondary to another trial, or a type 
						 of trial that tests for a relationship between 
						 a condition and a potential causal factor of the 
						 condition. 
						<ul>
							<li><span style="color: #000000;"><strong>Ancillary.</strong> 
							 Studies that are stimulated by, but are not 
							 a required part of, a main clinical trial/study, 
							 and that utilize patient or other resources 
							 of the main trial/study to generate information 
							 relevant to it. Ancillary studies must be 
							 linked to an active clinical research study 
							 and should include only patients accrued to 
							 that clinical research study. <span style="color: #000000;">Report 
							 only those studies that can be linked to individual 
							 patient or participant data</span>.</span></li>
							<li><span style="color: #000000;"><strong>Correlative.</strong> 
							 Laboratory-based studies using specimens to 
							 assess cancer risk, clinical outcomes, response 
							 to therapies, etc. Report only those studies 
							 that can be linked to individual patient or 
							 participant data.<br />
							</span></li>
						</ul>
					</div></li>
				</ul>
			</div></td>
		</tr>
		<tr role="row">
			<td class="confluenceTd"><p><strong>Primary Purpose*</strong></p></td>
			<td class="confluenceTd"><div class="content-wrapper">
				<ol>
					<li><p>Select the primary reason for conducting the 
					 trial. The following list provides valid values.</p>
					<ul class="conf-macro output-block" data-hasbody="false" 
							 data-macro-name="include">
						<li><strong>Treatment</strong>. Protocol is designed 
						 to evaluate one or more interventions for treating 
						 a disease, syndrome, or condition.</li>
						<li><strong>Prevention</strong>. Protocol is designed 
						 to assess one or more interventions aimed at preventing 
						 the development of a specific disease or health 
						 condition.</li>
						<li><strong>Supportive Care</strong>. Protocol 
						 is designed to evaluate one or more interventions 
						 where the primary intent is to maximize comfort, 
						 minimize side effects or mitigate against a decline 
						 in the subject's health or function. In general, 
						 supportive care interventions are not intended 
						 to cure a disease.</li>
						<li><strong>Screening</strong>. Protocol is designed 
						 to assess or examine methods of identifying a 
						 condition (or risk factors for a condition) in 
						 people who are not yet known to have the condition 
						 (or risk factor).</li>
						<li><strong>Diagnostic</strong>. Protocol is designed 
						 to evaluate one or more interventions aimed at 
						 identifying a disease or health condition.</li>
						<li><strong>Health Services Research</strong>. 
						 Protocol is designed to evaluate the delivery, 
						 processes, management, organization, or financing 
						 of health care.</li>
						<li><strong>Basic Science</strong>. Protocol is 
						 designed to examine the basic mechanism of action 
						 (e.g., physiology, biomechanics) of an intervention.</li>
						<li><strong>Device Feasibility</strong>. Protocol 
						 is designed to evaluate an intervention of a device 
						 product, to determine the feasibility of the product 
						 or to test a prototype device and not health outcomes. 
						 Such studies are conducted to confirm the design 
						 and operating specifications of a device before 
						 beginning a full clinical trial.</li>
						<li><strong>Other</strong>. Any purpose not described 
						 above.</li>
					</ul></li>
					<li>If none of the values is appropriate, select <strong>Other</strong>, 
					 and then enter the same Non-Interventional Study Type 
					 you selected earlier, either <em><code><strong>Observational</strong> 
					 </code></em>or<em> <code><strong>Ancillary</strong> 
					 <strong>-Correlative</strong> </code></em>, in the 
					 text field.</li>
				</ol>
				<div class="confluence-information-macro confluence-information-macro-information conf-macro output-block" 
					 data-hasbody="true" data-macro-name="info">
					<span class="aui-icon aui-icon-small aui-iconfont-info confluence-information-macro-icon">&#160;</span> 
					 
					<div class="confluence-information-macro-body">
						<p>The text field is displayed only after you have 
						 selected <strong>Other</strong>. The limit is 
						 200 characters; the system counts down the character 
						 numbers as you type.</p>
					</div>
				</div>
			</div></td>
		</tr>
		<tr role="row">
			<td class="confluenceTd"><p><strong>Study Model Code*<br />
			</strong></p></td>
			<td class="confluenceTd"><div class="content-wrapper">
				<ol>
					<li><p>Select the primary strategy for subject identification 
					 and follow-up. The following list provides valid values.</p>
					<ul class="conf-macro output-block" data-hasbody="false" 
							 data-macro-name="include">
						<li><strong>Cohort</strong>. Group of individuals, 
						 initially defined and composed, with common characteristics 
						 (e.g., condition, birth year), who are examined 
						 or traced over a given time period</li>
						<li><strong>Case-control</strong>. Group of individuals 
						 with specific characteristics (e.g., conditions 
						 or exposures) compared to group(s) with different 
						 characteristics, but otherwise similar</li>
						<li><strong>Case-only</strong>. Single group of 
						 individuals with specific characteristics</li>
						<li><strong>Case-crossover</strong>. Characteristics 
						 of case immediately prior to disease onset (sometimes 
						 called the hazard period) compared to characteristics 
						 of same case at a prior time (i.e., control period)</li>
						<li><strong>Ecologic or community studies</strong>. 
						 Geographically defined populations, such as countries 
						 or regions within a country, compared on a variety 
						 of environmental (e.g., air pollution intensity, 
						 hours of sunlight) and/or global measures not 
						 reducible to individual level characteristics 
						 (e.g., health care system, laws or policies median 
						 income, average fat intake, disease rate)</li>
						<li><strong>Family-based</strong>. Studies conducted 
						 among family members, such as genetic studies 
						 within families or twin studies and studies of 
						 family environment</li>
						<li><strong>Other</strong>. Any model not described 
						 above</li>
					</ul></li>
					<li>If the study model is <strong>Other</strong>, type 
					 a detailed description of the trial’s study model 
					 in the text field provided.</li>
				</ol>
				<div class="confluence-information-macro confluence-information-macro-information conf-macro output-block" 
					 data-hasbody="true" data-macro-name="info">
					<span class="aui-icon aui-icon-small aui-iconfont-info confluence-information-macro-icon">&#160;</span> 
					 
					<div class="confluence-information-macro-body">
						<p>The text field is displayed only after you have 
						 selected Other.</p>
					</div>
				</div>
			</div></td>
		</tr>
		<tr role="row">
			<td class="confluenceTd"><p><strong>Time Perspective Code*<br />
			</strong></p></td>
			<td class="confluenceTd"><div class="content-wrapper">
				<ol>
					<li><p>Select the <a name="ObsTiming" rel="nofollow"></a>temporal 
					 relationship of observation period to time of subject 
					 enrollment. The following list provides valid values.</p>
					<div class="conf-macro output-block" data-hasbody="false" 
						 data-macro-name="include">
						<ul>
							<li><strong>Prospective</strong> -<strong> 
							 </strong>Look forward using periodic observations 
							 collected predominantly following subject 
							 enrollment</li>
							<li><strong>Retrospective</strong> -<strong> 
							 </strong>Look back using observations collected 
							 predominantly prior to subject selection and 
							 enrollment</li>
							<li><strong>Cross</strong>-<strong>sectional</strong> 
							 -<strong> </strong>Observations or measurements 
							 made at a single point in time, usually at 
							 subject enrollment</li>
							<li><strong>Other</strong> -<strong> </strong>Any 
							 time perspective not described above</li>
						</ul>
						<p><a name="ObsTiming" rel="nofollow"></a></p>
					</div></li>
					<li>If the time perspective is <strong>Other</strong>, 
					 type a detailed description of the trial’s time perspective 
					 in the text field provided.</li>
				</ol>
				<div class="confluence-information-macro confluence-information-macro-information conf-macro output-block" 
					 data-hasbody="true" data-macro-name="info">
					<span class="aui-icon aui-icon-small aui-iconfont-info confluence-information-macro-icon">&#160;</span> 
					 
					<div class="confluence-information-macro-body">
						<p>The text field is displayed only after you have 
						 selected Other. The limit is 200 characters; the 
						 system counts down the character numbers as you 
						 type.</p>
					</div>
				</div>
			</div></td>
		</tr>
		<tr role="row">
			<td class="confluenceTd"><p><strong>Site Principal Investigator*</strong></p></td>
			<td class="confluenceTd"><p>Click <strong>Look Up Person</strong> 
			 and search for the principal investigator. See <a href="https://wiki.nci.nih.gov/display/CTRPdoc/Working+With+Persons+and+Organizations#WorkingWithPersonsandOrganizations-lookupperson"><span 
			 class="confluence-link">Looking Up Registered Persons</span> 
			 </a>.</p></td>
		</tr>
	</table>
</ol>
</body>
</html>
